⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
SPRY News
ARS Pharmaceuticals, Inc. Common Stock
Investors in ARS Pharmaceuticals, Inc. (SPRY): Protect Your Rights – Contact Levi & Korsinsky Before October 5, 2026
accessnewswire.com
SPRY
ROSEN, LEADING INVESTOR COUNSEL, Encourages ARS Pharmaceuticals, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - SPRY
accessnewswire.com
SPRY
Levi & Korsinsky Urges ARS Pharmaceuticals (SPRY) Shareholders to Act Before Lead Plaintiff Deadline October 5, 2026
accessnewswire.com
SPRY
ROSEN, SKILLED INVESTOR COUNSEL, Encourages ARS Pharmaceuticals, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – SPRY
globenewswire.com
SPRY
Form 8-K
sec.gov
SPRY
ARS Pharmaceuticals Outlines Strategic Priorities, including a Focused Commercial Strategy, and Reports Second Quarter 2026 Financial Results
globenewswire.com
SPRY
Contact Levi & Korsinsky by October 5, 2026 to Join Class Action Against ARS Pharmaceuticals, Inc. (SPRY)
accessnewswire.com
SPRY
Class Action Filed Against ARS Pharmaceuticals, Inc. (SPRY) Over Securities Violations - Contact Levi & Korsinsky Today
accessnewswire.com
SPRY
SPRY SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that ARS Pharmaceuticals Inc. Stockholders with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!
accessnewswire.com
SPRY
SPRY Deadline Alert: SueWallSt Reminds ARS Pharmaceuticals Inc. (SPRY) Investors of Securities Class Action Deadline on October 5, 2026
prnewswire.com
SPRY